CHF Solutions to Present at the Ladenburg Thalmann 2017 Healthcare Conference on September 26, 2017

EDEN PRAIRIE, Minn., Sept. 21, 2017 -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today that John Erb, CEO, will be a featured presenter at the Ladenburg Thalmann 2017 Healthcare Conference at the Sofitel Hotel in New York City on September 26, 2017 at 1:30pm eastern time. Interested parties can view the Company’s presentation on its Investor tab at https://www.chf-solutions.com.

About CHF Solutions

CHF Solutions, Inc. (NASDAQ:CHFS) is a medical device company focused on commercializing the Aquadex FlexFlow system for Aquapheresis^® therapy. The Aquadex FlexFlow system, is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. All treatments must be administered by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies. The company's objective is to improve the quality of life for patients with heart failure and related conditions. CHF Solutions is a Delaware corporation headquartered in Minneapolis with wholly owned subsidiaries in Australia and Ireland. The company has been listed on the NASDAQ Capital Market since February 2012.

For further information, please contact:

Claudia Napal Drayton
Chief Financial Officer
CHF Solutions Inc.
T: +1-952-345-4205

-or-

Bret Shapiro
Managing Partner
CORE IR
516 222 2560
[email protected]
www.coreir.com

Investor Relations:
CHF Solutions, Inc.
[email protected]